CRNX
Price
$54.00
Change
+$0.40 (+0.75%)
Updated
Dec 23, 04:59 PM (EDT)
85 days until earnings call
ELVN
Price
$23.48
Change
+$1.01 (+4.49%)
Updated
Dec 23, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

CRNX vs ELVN

Header iconCRNX vs ELVN Comparison
Open Charts CRNX vs ELVNBanner chart's image
Crinetics Pharmaceuticals
Price$54.00
Change+$0.40 (+0.75%)
Volume$7.83K
CapitalizationN/A
Enliven Therapeutics
Price$23.48
Change+$1.01 (+4.49%)
Volume$11.43K
CapitalizationN/A
CRNX vs ELVN Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ELVN commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and ELVN is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (CRNX: $53.60 vs. ELVN: $22.47)
Brand notoriety: CRNX and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 273% vs. ELVN: 178%
Market capitalization -- CRNX: $4.96B vs. ELVN: $1.1B
CRNX [@Biotechnology] is valued at $4.96B. ELVN’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 6 bearish.
  • ELVN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -0.11% price change this week, while ELVN (@Biotechnology) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.79%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +3.59%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 18, 2025.

ELVN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-1.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.96B) has a higher market cap than ELVN($1.1B). ELVN YTD gains are higher at: 62.355 vs. CRNX (50.646). ELVN has higher annual earnings (EBITDA): -100.07M vs. CRNX (-304.51M). CRNX has more cash in the bank: 863M vs. ELVN (292M). ELVN has less debt than CRNX: ELVN (85K) vs CRNX (52.5M). CRNX has higher revenues than ELVN: CRNX (1.04M) vs ELVN (0).
CRNXELVNCRNX / ELVN
Capitalization4.96B1.1B451%
EBITDA-304.51M-100.07M304%
Gain YTD50.64662.35581%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash863M292M296%
Total Debt52.5M85K61,765%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
10
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXELVN
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPD33.970.46
+1.37%
Simplify US Equity PLUS Dwnsd Cnvxty ETF
CVLC74.240.71
+0.97%
Calvert US Large-Cp Cor Rspnb ETF
GAMR66.810.21
+0.31%
Amplify Video Game Tech ETF
FLCB21.080.04
+0.19%
Franklin U.S. Core Bond ETF
SOLR24.56N/A
N/A
SmartETFs Sustainable Energy II ETF

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ARWR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.63%
ARWR - CRNX
48%
Loosely correlated
-0.26%
XENE - CRNX
47%
Loosely correlated
-0.69%
ELVN - CRNX
46%
Loosely correlated
-1.75%
RARE - CRNX
45%
Loosely correlated
+1.73%
PGEN - CRNX
44%
Loosely correlated
+5.07%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with OCEA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then OCEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-1.75%
OCEA - ELVN
48%
Loosely correlated
+12.75%
CRNX - ELVN
46%
Loosely correlated
+1.63%
BPMC - ELVN
40%
Loosely correlated
+1.36%
VYGR - ELVN
39%
Loosely correlated
+1.05%
ACLX - ELVN
38%
Loosely correlated
+0.44%
More